Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation.

Prinz Vavricka, B M; Hofbauer, G F L; Dummer, R; French, L E; Kempf, W

Prinz Vavricka, B M; Hofbauer, G F L; Dummer, R; French, L E; Kempf, W.

Affiliation

Prinz Vavricka BM; Department of Dermatology, University Hospital, Zürich, Switzerland.

Clin Exp Dermatol ; 37(6): 620-5, 2012 Aug.

Article in En | MEDLINE | ID: mdl-22300351

Subject(s)

Adjuvants, Immunologic/administration & dosage; Aminoquinolines/administration & dosage; Antineoplastic Agents/administration & dosage; Kidney Transplantation/adverse effects; Sarcoma, Kaposi/drug therapy; Skin Neoplasms/drug therapy; Administration, Topical; Aged; Antigens, CD/metabolism; Female; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Sarcoma, Kaposi/etiology; Sarcoma, Kaposi/immunology; Skin Neoplasms/etiology; Skin Neoplasms/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Kaposi / Skin Neoplasms / Adjuvants, Immunologic / Kidney Transplantation / Aminoquinolines / Antineoplastic Agents Type of study: Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Dermatol Year: 2012 Document type: Article Affiliation country: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google